Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 091314
Company: GLENMARK GENERICS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ADAPALENE ADAPALENE 0.1% GEL;TOPICAL Prescription AB No No
ADAPALENE ADAPALENE 0.1% GEL;TOPICAL Over-the-counter None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/01/2010 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/09/2019 SUPPL-5 Labeling-Container/Carton Labels, Labeling-Package Insert

Label is not available on this site.

ADAPALENE

GEL;TOPICAL; 0.1%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADAPALENE ADAPALENE 0.1% GEL;TOPICAL Prescription No AB 091314 GLENMARK GENERICS
ADAPALENE ADAPALENE 0.1% GEL;TOPICAL Prescription No AB 090962 P AND L

ADAPALENE

The products listed here are over-the-counter (OTC) drugs and do not receive therapeutic equivalence ratings. They may not be interchangeable.

GEL;TOPICAL; 0.1%
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD Application No. Company
ADAPALENE ADAPALENE 0.1% GEL;TOPICAL Over-the-counter No 091314 GLENMARK GENERICS
DIFFERIN ADAPALENE 0.1% GEL;TOPICAL Over-the-counter Yes 020380 GALDERMA LABS LP

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English